-
LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases
prnasia
January 07, 2022
LISCure Biosciences Inc., a leading biotech focused on microbial-based therapeutics, announced that it has executed a research collaboration agreement with Mayo Clinic for new drug development for rare liver diseases.
-
Mayo Clinic and nference Study Links Pre-Existing Conditions to Short- and Long-Term COVID-19 Complications
prnewswire
July 28, 2021
nference announced publication of a study in npj Digital Medicine which establishes relationships between specific pre-existing conditions and complications from COVID-19 infection.
-
LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic
prnasia
July 27, 2021
LISCure Biosciences, Inc. has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo Clinic to advance LISCure's microbiome therapeutics in non-alcoholic steatohepatitis (NASH).
-
Novel ionic liquid enables uniform chemotherapy delivery in solid tumours
europeanpharmaceuticalreview
February 19, 2021
Co-injecting doxorubicin with LATTE, a novel ionic liquid formulation, resulted in uniform chemotherapy delivery and successful ablation in solid tumours.
-
Mayo finds convalescent plasma safe for diverse patients with COVID-19
worldpharmanews
June 22, 2020
Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients.
-
Ultromics, Mayo Clinic Collaborate to Rapidly Assess COVID-19 Patients Using AI
americanpharmaceuticalreview
May 13, 2020
A joint UK-US research team is applying an artificial intelligence system to map for the first time how the COVID-19 virus attacks the heart with such deadly impact.
-
Mayo Clinic, Oxford Uni announce team of physicians
pharmatimes
June 11, 2019
Mayo Clinic Healthcare has announced a new team of physicians in partnership with Oxford University Clinic, to coincide with the opening of its new preventative healthcare facility, set to open its doors this summer.
-
Baxter partners up with Mayo Clinic for new "centre of exellence" in renal care
pharmafile
November 20, 2018
American pharma firm Baxter has announced a new partnership with the Mayo Clinic in a bid to establish a “renal care centre of excellence” in the US.
-
Mayo Clinic, OmniTier speed up de novo genome sequencing
fiercebiotech
August 16, 2018
In a joint study, Mayo Clinic and OmniTier have shown that de novo genome sequencing—which does not use a reference genome—can be used in whole genome sequencing without the need for “supercomputing-level resources,” making the speedier sequencing process
-
Mayo Clinic pinpoints genes that raise the risk of triple-negative breast cancer
fiercebiotech
August 08, 2018
The ability to identify women who face the highest risk of triple-negative breast cancer could save lives, but only one inherited mutation—in the gene BRCA1—has been definitively linked to this subtype of the disease.....